Veterinary Antibiotocs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, and Others); Formulation (Premixes, Injections, Oral Powders, Oral Solutions, and Others); End Use (Farm Animals, Companion Animals, and Others), and Geography

Report Code: TIPRE00022340 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Veterinary Antibiotics are used to treat, control or prevent animals against diseases. These are also used as growth promoters and play a vital role in maintaining animal health. Antibiotics are generally the anti-bacterial compounds that have a direct effect on bacteria, thereby preventing the infection in farm and companion animals. Growing concerns over antibiotic resistance in human beings coupled with rising demand for milk, eggs and meat is influencing the veterinary antibiotic market across the globe.

MARKET DYNAMICS

Factors driving the growth of the veterinary antibiotics market are high predominance of zoonotic diseases, and growing importance of immunization across the globe. However, rising threat of antibiotic resistance and stringent regulations imposed by FDA are likely to hamper the growth of the market. Moreover, rise in demand for pet health insurance combined with healthcare expenditure in the veterinary antibiotics is further likely to create growth opportunities in the market.

MARKET SCOPE

The "Veterinary Antibiotics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of veterinary antibiotics market with detailed market segmentation by product, formulation, and end use. The veterinary antibiotics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in veterinary antibiotics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The veterinary antibiotics market is segmented on the basis of product, formulation, and end use. On the basis of product, the market is categorized as anti-parasitic, anti-bacterial, non-steroidal anti-inflammatory drug, and others. On the basis of formulation, the market is categorized as premixes, injections, oral powders, oral solutions, and others. On the basis of end use, the market is categorized as farm animals, companion animals, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the veterinary antibiotics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The veterinary antibiotics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting veterinary antibiotics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the veterinary antibiotics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the veterinary antibiotics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from veterinary antibiotics market are anticipated to have lucrative growth opportunities in the future with the rising demand for veterinary antibiotics in the global market. Below mentioned is the list of few companies engaged in the veterinary antibiotics market.

The report also includes the profiles of key players in veterinary antibiotics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
  •  Zoetis, Inc.
  •  Merck & Co.
  •  Bayer AG.
  •  Sanofi
  •  Eli Lilly
  •  Ceva Sante Animale.
  •  Boehringer Ingelheim GmbH
  •  IPCA Laboratories
  •  Johnson & Johnson
  •  Kyowa Hakko Kirin Pharma
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Veterinary Antibiotics Market - By Product
1.3.2 Veterinary Antibiotics Market - By Formulation
1.3.3 Veterinary Antibiotics Market - By End Use
1.3.4 Veterinary Antibiotics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VETERINARY ANTIBIOTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VETERINARY ANTIBIOTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VETERINARY ANTIBIOTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. VETERINARY ANTIBIOTICS - GLOBAL MARKET OVERVIEW
6.2. VETERINARY ANTIBIOTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. VETERINARY ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ANTI-PARASITIC
7.3.1. Overview
7.3.2. Anti-parasitic Market Forecast and Analysis
7.4. ANTI-BACTERIAL
7.4.1. Overview
7.4.2. Anti-bacterial Market Forecast and Analysis
7.5. NON-STEROIDAL ANTI-INFLAMMATORY DRUG
7.5.1. Overview
7.5.2. Non-steroidal anti-inflammatory drug Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. VETERINARY ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - FORMULATION
8.1. OVERVIEW
8.2. FORMULATION MARKET FORECASTS AND ANALYSIS
8.3. PREMIXES
8.3.1. Overview
8.3.2. Premixes Market Forecast and Analysis
8.4. INJECTIONS
8.4.1. Overview
8.4.2. Injections Market Forecast and Analysis
8.5. ORAL POWDERS
8.5.1. Overview
8.5.2. Oral Powders Market Forecast and Analysis
8.6. ORAL SOLUTIONS
8.6.1. Overview
8.6.2. Oral Solutions Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. VETERINARY ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
9.1. OVERVIEW
9.2. END USE MARKET FORECASTS AND ANALYSIS
9.3. FARM ANIMALS
9.3.1. Overview
9.3.2. Farm Animals Market Forecast and Analysis
9.4. COMPANION ANIMALS
9.4.1. Overview
9.4.2. Companion Animals Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. VETERINARY ANTIBIOTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Veterinary Antibiotics Market Overview
10.1.2 North America Veterinary Antibiotics Market Forecasts and Analysis
10.1.3 North America Veterinary Antibiotics Market Forecasts and Analysis - By Product
10.1.4 North America Veterinary Antibiotics Market Forecasts and Analysis - By Formulation
10.1.5 North America Veterinary Antibiotics Market Forecasts and Analysis - By End Use
10.1.6 North America Veterinary Antibiotics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Veterinary Antibiotics Market
10.1.6.1.1 United States Veterinary Antibiotics Market by Product
10.1.6.1.2 United States Veterinary Antibiotics Market by Formulation
10.1.6.1.3 United States Veterinary Antibiotics Market by End Use
10.1.6.2 Canada Veterinary Antibiotics Market
10.1.6.2.1 Canada Veterinary Antibiotics Market by Product
10.1.6.2.2 Canada Veterinary Antibiotics Market by Formulation
10.1.6.2.3 Canada Veterinary Antibiotics Market by End Use
10.1.6.3 Mexico Veterinary Antibiotics Market
10.1.6.3.1 Mexico Veterinary Antibiotics Market by Product
10.1.6.3.2 Mexico Veterinary Antibiotics Market by Formulation
10.1.6.3.3 Mexico Veterinary Antibiotics Market by End Use
10.2. EUROPE
10.2.1 Europe Veterinary Antibiotics Market Overview
10.2.2 Europe Veterinary Antibiotics Market Forecasts and Analysis
10.2.3 Europe Veterinary Antibiotics Market Forecasts and Analysis - By Product
10.2.4 Europe Veterinary Antibiotics Market Forecasts and Analysis - By Formulation
10.2.5 Europe Veterinary Antibiotics Market Forecasts and Analysis - By End Use
10.2.6 Europe Veterinary Antibiotics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Veterinary Antibiotics Market
10.2.6.1.1 Germany Veterinary Antibiotics Market by Product
10.2.6.1.2 Germany Veterinary Antibiotics Market by Formulation
10.2.6.1.3 Germany Veterinary Antibiotics Market by End Use
10.2.6.2 France Veterinary Antibiotics Market
10.2.6.2.1 France Veterinary Antibiotics Market by Product
10.2.6.2.2 France Veterinary Antibiotics Market by Formulation
10.2.6.2.3 France Veterinary Antibiotics Market by End Use
10.2.6.3 Italy Veterinary Antibiotics Market
10.2.6.3.1 Italy Veterinary Antibiotics Market by Product
10.2.6.3.2 Italy Veterinary Antibiotics Market by Formulation
10.2.6.3.3 Italy Veterinary Antibiotics Market by End Use
10.2.6.4 Spain Veterinary Antibiotics Market
10.2.6.4.1 Spain Veterinary Antibiotics Market by Product
10.2.6.4.2 Spain Veterinary Antibiotics Market by Formulation
10.2.6.4.3 Spain Veterinary Antibiotics Market by End Use
10.2.6.5 United Kingdom Veterinary Antibiotics Market
10.2.6.5.1 United Kingdom Veterinary Antibiotics Market by Product
10.2.6.5.2 United Kingdom Veterinary Antibiotics Market by Formulation
10.2.6.5.3 United Kingdom Veterinary Antibiotics Market by End Use
10.2.6.6 Rest of Europe Veterinary Antibiotics Market
10.2.6.6.1 Rest of Europe Veterinary Antibiotics Market by Product
10.2.6.6.2 Rest of Europe Veterinary Antibiotics Market by Formulation
10.2.6.6.3 Rest of Europe Veterinary Antibiotics Market by End Use
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Veterinary Antibiotics Market Overview
10.3.2 Asia-Pacific Veterinary Antibiotics Market Forecasts and Analysis
10.3.3 Asia-Pacific Veterinary Antibiotics Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Veterinary Antibiotics Market Forecasts and Analysis - By Formulation
10.3.5 Asia-Pacific Veterinary Antibiotics Market Forecasts and Analysis - By End Use
10.3.6 Asia-Pacific Veterinary Antibiotics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Veterinary Antibiotics Market
10.3.6.1.1 Australia Veterinary Antibiotics Market by Product
10.3.6.1.2 Australia Veterinary Antibiotics Market by Formulation
10.3.6.1.3 Australia Veterinary Antibiotics Market by End Use
10.3.6.2 China Veterinary Antibiotics Market
10.3.6.2.1 China Veterinary Antibiotics Market by Product
10.3.6.2.2 China Veterinary Antibiotics Market by Formulation
10.3.6.2.3 China Veterinary Antibiotics Market by End Use
10.3.6.3 India Veterinary Antibiotics Market
10.3.6.3.1 India Veterinary Antibiotics Market by Product
10.3.6.3.2 India Veterinary Antibiotics Market by Formulation
10.3.6.3.3 India Veterinary Antibiotics Market by End Use
10.3.6.4 Japan Veterinary Antibiotics Market
10.3.6.4.1 Japan Veterinary Antibiotics Market by Product
10.3.6.4.2 Japan Veterinary Antibiotics Market by Formulation
10.3.6.4.3 Japan Veterinary Antibiotics Market by End Use
10.3.6.5 South Korea Veterinary Antibiotics Market
10.3.6.5.1 South Korea Veterinary Antibiotics Market by Product
10.3.6.5.2 South Korea Veterinary Antibiotics Market by Formulation
10.3.6.5.3 South Korea Veterinary Antibiotics Market by End Use
10.3.6.6 Rest of Asia-Pacific Veterinary Antibiotics Market
10.3.6.6.1 Rest of Asia-Pacific Veterinary Antibiotics Market by Product
10.3.6.6.2 Rest of Asia-Pacific Veterinary Antibiotics Market by Formulation
10.3.6.6.3 Rest of Asia-Pacific Veterinary Antibiotics Market by End Use
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Veterinary Antibiotics Market Overview
10.4.2 Middle East and Africa Veterinary Antibiotics Market Forecasts and Analysis
10.4.3 Middle East and Africa Veterinary Antibiotics Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Veterinary Antibiotics Market Forecasts and Analysis - By Formulation
10.4.5 Middle East and Africa Veterinary Antibiotics Market Forecasts and Analysis - By End Use
10.4.6 Middle East and Africa Veterinary Antibiotics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Veterinary Antibiotics Market
10.4.6.1.1 South Africa Veterinary Antibiotics Market by Product
10.4.6.1.2 South Africa Veterinary Antibiotics Market by Formulation
10.4.6.1.3 South Africa Veterinary Antibiotics Market by End Use
10.4.6.2 Saudi Arabia Veterinary Antibiotics Market
10.4.6.2.1 Saudi Arabia Veterinary Antibiotics Market by Product
10.4.6.2.2 Saudi Arabia Veterinary Antibiotics Market by Formulation
10.4.6.2.3 Saudi Arabia Veterinary Antibiotics Market by End Use
10.4.6.3 U.A.E Veterinary Antibiotics Market
10.4.6.3.1 U.A.E Veterinary Antibiotics Market by Product
10.4.6.3.2 U.A.E Veterinary Antibiotics Market by Formulation
10.4.6.3.3 U.A.E Veterinary Antibiotics Market by End Use
10.4.6.4 Rest of Middle East and Africa Veterinary Antibiotics Market
10.4.6.4.1 Rest of Middle East and Africa Veterinary Antibiotics Market by Product
10.4.6.4.2 Rest of Middle East and Africa Veterinary Antibiotics Market by Formulation
10.4.6.4.3 Rest of Middle East and Africa Veterinary Antibiotics Market by End Use
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Veterinary Antibiotics Market Overview
10.5.2 South and Central America Veterinary Antibiotics Market Forecasts and Analysis
10.5.3 South and Central America Veterinary Antibiotics Market Forecasts and Analysis - By Product
10.5.4 South and Central America Veterinary Antibiotics Market Forecasts and Analysis - By Formulation
10.5.5 South and Central America Veterinary Antibiotics Market Forecasts and Analysis - By End Use
10.5.6 South and Central America Veterinary Antibiotics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Veterinary Antibiotics Market
10.5.6.1.1 Brazil Veterinary Antibiotics Market by Product
10.5.6.1.2 Brazil Veterinary Antibiotics Market by Formulation
10.5.6.1.3 Brazil Veterinary Antibiotics Market by End Use
10.5.6.2 Argentina Veterinary Antibiotics Market
10.5.6.2.1 Argentina Veterinary Antibiotics Market by Product
10.5.6.2.2 Argentina Veterinary Antibiotics Market by Formulation
10.5.6.2.3 Argentina Veterinary Antibiotics Market by End Use
10.5.6.3 Rest of South and Central America Veterinary Antibiotics Market
10.5.6.3.1 Rest of South and Central America Veterinary Antibiotics Market by Product
10.5.6.3.2 Rest of South and Central America Veterinary Antibiotics Market by Formulation
10.5.6.3.3 Rest of South and Central America Veterinary Antibiotics Market by End Use
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VETERINARY ANTIBIOTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. VETERINARY ANTIBIOTICS MARKET, KEY COMPANY PROFILES
13.1. ZOETIS, INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MERCK AND CO
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAYER AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANOFI
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ELI LILLY
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. CEVA SANTE ANIMALE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BOEHRINGER INGELHEIM GMBH
13ey Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. IPCA LABORATORIES
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. JOHNSON AND JOHNSON
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. KYOWA HAKKO KIRIN PHARMA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Zoetis, Inc.
2. Merck & Co.
3. Bayer AG.
4. Sanofi
5. Eli Lilly
6. Ceva Sante Animale.
7. Boehringer Ingelheim GmbH
8. IPCA Laboratories
9. Johnson & Johnson
10. Kyowa Hakko Kirin Pharma
11. Merck
12. Mirabilia Sciences Pvt.
13. Novartis
14. Pfizer
15. Sanofi-Aventis
16. SRS Pharmaceuticals
17. Teva Pharmaceutical Industries Ltd
18. F. Hoffmann-La Roche
19. GlaxoSmithKline
20. Helsinn Healthcare
TIPRE00022340
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking